FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123355624> ?p ?o ?g. }

• W2123355624 endingPage "1470" @default.
• W2123355624 startingPage "1454" @default.
• W2123355624 abstract "The dipeptidyl peptidase 4 (DPP-4) inhibitors enhance the body's own ability to control blood glucose by increasing the active levels of incretin hormones in the body. Their mechanism of action is distinct from any existing class of oral glucose-lowering agents. They control elevated blood glucose by triggering pancreatic insulin secretion, suppressing pancreatic glucagon secretion, and signalling the liver to reduce glucose production. The leading DPP-4 inhibitors have shown clinically significant HbA1c reductions up to 1 year of treatment and offer many potential advantages over existing diabetes therapies including a low risk of hypoglycaemia, no effect on body weight, and the potential, based on animal and in vitro studies, for the regeneration and differentiation of pancreatic β-cells. They are efficacious as monotherapy and also in combination with commonly prescribed antidiabetic agents and are suitable for once-daily oral dosing. Consequently, many DPP-4 inhibitors such as vildagliptin (Galvus; LAF-237), sitagliptin (Januvia; MK-0431), and saxagliptin (BMS-477118) have advanced into late-stage human clinical trials. Search strategy and selection criteria This review was built on a systematic MEDLINE search for publications on the subject with the key words: DPP-4 inhibitor; vildagliptin (LAF-237); sitagliptin (MK-0431); saxagliptin (BMS-477118); and type 2 diabetes; up to August 2006. Meeting abstracts were also searched, as much of the data currently only exists in abstract form. Take home message for clinician The DPP-4 inhibitors appear to have great potential for the treatment of type 2 diabetes, but time will tell if this will be realized. While they do not lower glucose to a greater extent than existing therapies, they offer many potential advantages, including the ability to achieve sustainable reductions in HbA1c with a well-tolerated agent that has a low risk of hypoglycaemia and no weight gain, and which can be administered as a once-daily oral dose." @default.
• W2123355624 created "2016-06-24" @default.
• W2123355624 creator A5023295361 @default.
• W2123355624 date "2006-10-11" @default.
• W2123355624 modified "2023-10-04" @default.
• W2123355624 title "DPP-4 inhibitors and their potential role in the management of type 2 diabetes" @default.
• W2123355624 cites W1553821695 @default.
• W2123355624 cites W1967130535 @default.
• W2123355624 cites W1976403777 @default.
• W2123355624 cites W1978691530 @default.
• W2123355624 cites W1978953702 @default.
• W2123355624 cites W1986085856 @default.
• W2123355624 cites W1987182389 @default.
• W2123355624 cites W1991565451 @default.
• W2123355624 cites W1993287695 @default.
• W2123355624 cites W1994174156 @default.
• W2123355624 cites W1994743271 @default.
• W2123355624 cites W2012437459 @default.
• W2123355624 cites W2016193795 @default.
• W2123355624 cites W2022101780 @default.
• W2123355624 cites W2028707869 @default.
• W2123355624 cites W2028849170 @default.
• W2123355624 cites W2030347165 @default.
• W2123355624 cites W2031468509 @default.
• W2123355624 cites W2036167841 @default.
• W2123355624 cites W2040065191 @default.
• W2123355624 cites W2043121816 @default.
• W2123355624 cites W2049323977 @default.
• W2123355624 cites W2054185381 @default.
• W2123355624 cites W2054564814 @default.
• W2123355624 cites W2074511950 @default.
• W2123355624 cites W2076880341 @default.
• W2123355624 cites W2081733901 @default.
• W2123355624 cites W2083473802 @default.
• W2123355624 cites W2084363158 @default.
• W2123355624 cites W2087707716 @default.
• W2123355624 cites W2093303670 @default.
• W2123355624 cites W2107076497 @default.
• W2123355624 cites W2108771199 @default.
• W2123355624 cites W2109157463 @default.
• W2123355624 cites W2123629330 @default.
• W2123355624 cites W2139470224 @default.
• W2123355624 cites W2141880555 @default.
• W2123355624 cites W2143014102 @default.
• W2123355624 cites W2145140318 @default.
• W2123355624 cites W2153449155 @default.
• W2123355624 cites W2154615287 @default.
• W2123355624 cites W2161923520 @default.
• W2123355624 cites W2162934281 @default.
• W2123355624 cites W2164961795 @default.
• W2123355624 cites W2167621077 @default.
• W2123355624 cites W2169558934 @default.
• W2123355624 cites W2326146948 @default.
• W2123355624 cites W4234825176 @default.
• W2123355624 cites W70331709 @default.
• W2123355624 doi "https://doi.org/10.1111/j.1742-1241.2006.01178.x" @default.
• W2123355624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17073841" @default.
• W2123355624 hasPublicationYear "2006" @default.
• W2123355624 type Work @default.
• W2123355624 sameAs 2123355624 @default.
• W2123355624 citedByCount "327" @default.
• W2123355624 countsByYear W21233556242012 @default.
• W2123355624 countsByYear W21233556242013 @default.
• W2123355624 countsByYear W21233556242014 @default.
• W2123355624 countsByYear W21233556242015 @default.
• W2123355624 countsByYear W21233556242016 @default.
• W2123355624 countsByYear W21233556242017 @default.
• W2123355624 countsByYear W21233556242018 @default.
• W2123355624 countsByYear W21233556242019 @default.
• W2123355624 countsByYear W21233556242020 @default.
• W2123355624 countsByYear W21233556242021 @default.
• W2123355624 countsByYear W21233556242022 @default.
• W2123355624 countsByYear W21233556242023 @default.
• W2123355624 crossrefType "journal-article" @default.
• W2123355624 hasAuthorship W2123355624A5023295361 @default.
• W2123355624 hasBestOaLocation W21233556241 @default.
• W2123355624 hasConcept C126322002 @default.
• W2123355624 hasConcept C134018914 @default.
• W2123355624 hasConcept C156490143 @default.
• W2123355624 hasConcept C2776453732 @default.
• W2123355624 hasConcept C2777180221 @default.
• W2123355624 hasConcept C2778881409 @default.
• W2123355624 hasConcept C2779284873 @default.
• W2123355624 hasConcept C2779306644 @default.
• W2123355624 hasConcept C2780282729 @default.
• W2123355624 hasConcept C555293320 @default.
• W2123355624 hasConcept C71924100 @default.
• W2123355624 hasConcept C98274493 @default.
• W2123355624 hasConceptScore W2123355624C126322002 @default.
• W2123355624 hasConceptScore W2123355624C134018914 @default.
• W2123355624 hasConceptScore W2123355624C156490143 @default.
• W2123355624 hasConceptScore W2123355624C2776453732 @default.
• W2123355624 hasConceptScore W2123355624C2777180221 @default.
• W2123355624 hasConceptScore W2123355624C2778881409 @default.
• W2123355624 hasConceptScore W2123355624C2779284873 @default.
• W2123355624 hasConceptScore W2123355624C2779306644 @default.
• W2123355624 hasConceptScore W2123355624C2780282729 @default.
• W2123355624 hasConceptScore W2123355624C555293320 @default.

• next